Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Change in Acquisitions & Divestments (2021)

Cellectis (CLLS) posted quarterly Change in Acquisitions & Divestments of -$105.4 million for Q2 2024, down 6128.9% quarter-over-quarter from -$1.7 million in Q1 2024.

Analysis

Cellectis (CLLS) Change in Acquisitions & Divestments (2021) Analysis & Trends

Cellectis' Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at -$105.4 million for Q2 2024.

  • In Q2 2024, Change in Acquisitions & Divestments changed N/A year-over-year to -$105.4 million; the TTM figure through Jun 2024 stood at -$107.0 million (changed N/A YoY), while the FY2023 annual figure was -$13.4 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments for Q2 2024 stood at -$105.4 million, down from -$1.7 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $25.9 million in Q4 2020, with the low at -$105.4 million in Q2 2024.
  • The 4-year median for Change in Acquisitions & Divestments is $1.7 million (2021), against an average of -$7.3 million.
  • Peak annual rise in Change in Acquisitions & Divestments reached 862800.0% in 2020, while the deepest fall reached 23939.51% in 2020.
  • Cellectis' Change in Acquisitions & Divestments stood at $25.9 million in 2020, then slumped by 145.25% to -$11.7 million in 2021, then soared by 97.21% to -$326000.0 in 2022, then tumbled by 32229.14% to -$105.4 million in 2024.
  • Business Quant data shows CLLS's Change in Acquisitions & Divestments at -$105.4 million in Q2 2024, -$1.7 million in Q1 2024, and -$326000.0 in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Cellectis 321.90 Mn 155.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 8.65 Mn